Bioxytran, Inc. (OTCMKTS:BIXT) Sees Large Growth in Short Interest

Bioxytran, Inc. (OTCMKTS:BIXT) was the recipient of a large increase in short interest in December. As of December 15th, there was short interest totalling 77,600 shares, an increase of 254.3% from the November 30th total of 21,900 shares. Based on an average daily volume of 83,100 shares, the days-to-cover ratio is currently 0.9 days.

Bioxytran Stock Performance

Shares of BIXT traded up $0.00 during trading hours on Friday, hitting $0.09. The stock had a trading volume of 35,834 shares, compared to its average volume of 82,381. The firm has a market capitalization of $8.05 million, a price-to-earnings ratio of -9.28 and a beta of -0.80. The firm has a 50-day moving average price of $0.09 and a 200 day moving average price of $0.10. Bioxytran has a fifty-two week low of $0.08 and a fifty-two week high of $0.16.

About Bioxytran

Bioxytran, Inc, a clinical stage pharmaceutical company, focuses on the development, manufacture, and commercialization of therapeutic drugs to address hypoxia in humans. The company’s lead drug candidate is BXT-25, an oxygen-carrying small molecule consisting of bovine hemoglobin stabilized with a co-polymer for use in the treatment of hypoxic conditions in the brain resulting from stroke, and hypoxic conditions in wounds to prevent necrosis and to promote healing.